Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.06 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.083 | 0.07 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.07 |